Twice-Daily Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Lung Function Improvements In The Augment COPD Trial In Patients With Moderate To Severe COPD

被引：0

作者：

D'Urzo, A. D. ^{[1
]}

Rennard, S. I. ^{[2
]}

Kerwin, E. M. ^{[3
]}

Mergel, V. ^{[4
]}

Leselbaum, A. ^{[5
]}

Caracta, C. ^{[4
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Univ Nebraska Med Ctr, Omaha, NE USA

[3] Clin Res Inst, Medford, OR USA

[4] Forest Res Inst, Jersey City, NJ USA

[5] Almirall SA, Barcelona, Spain

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A3776

引用

页数：1

共 50 条

[1] The AUGMENT COPD Trial: Efficacy and Safety of a Fixed-Dose Combination of Aclidinium Bromide and Formoterol Fumarate in COPD Patients
D'Urzo, Anthony
Rennard, Stephen
Mergel, Victor
Gil, Esther Garcia
Leselbaum, Anne
Caracta, Cynthia
CHEST, 2014, 145 (03)
[2] Long-Term Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate In Patients With Moderate To Severe COPD: The Augment COPD Extension Trial
Rennard, S. I.
D'Urzo, A. D.
Donohue, J. F.
He, T.
Shrestha, P.
Leselbaum, A.
Caracta, C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[3] Efficacy Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate On Bronchodilation Over 1 Year: Augment COPD Extension Trial In Patients With Moderate To Severe COPD
D'Urzo, A. D.
Rennard, S. I.
Kerwin, E. M.
He, T.
Leselbaum, A.
Caracta, C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[4] Fixed-Dose Combination Of Aclidinium Bromide/formoterol Fumarate Improve Breathlessness And Health Status In COPD Patients: Augment COPD Trial
Rennard, S. I.
D'Urzo, A. D.
Jones, P. W.
Mergel, V.
Leselbaum, A.
Caracta, C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[5] Efficacy and safety of fixed-dose combination aclidinium bromide/formoterol fumarate in patients with COPD: Results from the AUGMENT COPD trial
D'Urzo, Anthony
Mergel, Victor
Leselbaum, Anne
Caracta, Cynthia
CHEST, 2013, 144 (04)
[6] Lung function improvements with twice-daily aclidinium/formoterol fixed-dose combination in two 24-week studies in patients with COPD
Singh, Dave
D'Urzo, Anthony
Jones, Paul
Serra, Cristina
Mergel, Victor
Caracta, Cynthia
Leselbaum, Anne
EUROPEAN RESPIRATORY JOURNAL, 2014, 44
[7] Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In Patients With Moderate To Severe COPD, Stratified By COPD Severity
D'Urzo, A.
Singh, S. D.
Kerwin, E. M.
Lakkis, H.
Chuecos, F.
De Miquel, G.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
[8] Dose-Ranging Study of 2 Fixed-Dose Combinations of Twice-Daily Aclidinium Bromide Plus Formoterol in Patients With Moderate to Severe COPD
Kerwin, Edward
Lapidus, Robert
Leselbaum, Anne
Ortiz, Stephan
Rowe, Paul
Caracta, Cynthia
CHEST, 2013, 144 (04)
[9] Long-term Safety of a Fixed-Dose Combination of Aclidinium Bromide/Formoterol Fumarate in Patients With Stable Moderate to Severe COPD
Make, Barry
Donohue, James
Zhong, Xiaoyun
Leselbaum, Anne
Caracta, Cynthia
CHEST, 2014, 145 (03)
[10] Lung Function And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Results Of A 1-Year Trial In Patients With COPD
Make, B. J.
Donohue, J. F.
Soong, W.
Zhong, X.
Leselbaum, A.
Caracta, C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189

← 1 2 3 4 5 →